As the coronavirus disease 2019 COVID-19; the disease caused by SARS-CoV-2 pandemic took hold in North America rheumatology clinics across the continent were inundated with phone calls from patients with systemic lupus erythematosus SLE who were understandably fearful of COVID-19. One of the most common questions from patients was whether they should stop taking their medications. Possible Consequences of a Shortage of Hydroxychloroquine for Patients with Systemic Lupus Erythematosus amid the COVID-19 Pandemic.